Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 4 The top ten significantly enriched pathways of targeted ribosomal proteins in the predicted PPI, based on DAVID and KOBAS analysis

From: In silico evidence of de novo interactions between ribosomal and Epstein - Barr virus proteins

Platform

Pathway database

Pathway names

p-value

DAVID

KEGG

Ribosome

2.68e-43

Reactome

3′ -UTR-mediated translational regulation

2.07e-41

Reactome

Influenza Infection

8.22e-37

Reactome

Metabolism of proteins

6.79e-33

Reactome

Gene Expression

3.96e-27

Reactome

APC-Cdc20 mediated degradation of Nek2A

0.002563

Reactome

Regulation of activated PAK-2p34 by proteasome mediated degradation

0.014244

Reactome

Signaling by EGFR

0.014717

Reactome

APC/C: Cdh1-mediated degradation of Skp2

0.026468

Reactome

Signaling by Wnt

0.026468

KOBAS

Reactome

Viral mRNA Translation

4.96e-55

Reactome

Peptide chain elongation

4.96e-55

Reactome

Selenocysteine synthesis

5.58e-55

Reactome

Eukaryotic Translation Elongation

6.99e-55

Reactome

Eukaryotic Translation Termination

7.83e-55

Reactome

Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)

1.26e-54

Reactome

Formation of a pool of free 40S subunits

2.05e-54

Reactome

L13a-mediated translational silencing of Ceruloplasmin expression

1.50e-53

Reactome

GTP hydrolysis and joining of the 60S ribosomal subunit

1.61e-53

Reactome

Nonsense-Mediated Decay (NMD)

3.61e-53